UniProtKB/Swiss-Prot Q8WVM0: Variant p.Thr211Ala

Dimethyladenosine transferase 1, mitochondrial
Gene: TFB1M
Feedback?

Variant information Variant position:

211 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Threonine (T) to Alanine (A) at position 211 (T211A, p.Thr211Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (T) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs769497533 [ dbSNP | Ensembl ]

Sequence information Variant position:

211 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

346 The length of the canonical sequence.
Location on the sequence:

KQRSRLSVMAQYLCNVRHIF T IPGQAFVPKPEVDVGVVHFT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         KQRSRLSVMAQYLCNVRHIFTIPGQAFVPKPEVDVGVVHFT

Mouse                         KQHSRLSIMAQYLCNVEHLFTIPGKAFVPKPKVDVGVVHLT

Rat                           KQRSRLSIMAQYLCNVEHLFTIPGKAFVPKPEVDVGVVHLM

Bovine                        KQRSRLSIMAQYLCDVQHILTIPGQAFVPKPEVDSGVVHFT

Xenopus laevis                KQRSRLSIMSQYLCNVKNCFTIPGRAFIPKPKVDVGVVHLT

Xenopus tropicalis            KQRSRLSIMAQNLCNVKNCFTIPGRAFVPKPEVDVGVVHFT

Caenorhabditis elegans        DTRSRISIMSQYVAEPKMVFQISGSCFVPRPQVDVGVVRFV

Drosophila                    EQRCRLSVMSQVWTEPVMKFTIPGKAFVPKPQVDVGVVKLI

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	28 – 346	Dimethyladenosine transferase 1, mitochondrial
Mutagenesis	220 – 220	K -> A. Abolishes methyltransferase activity. Does not affect SAM-binding, DNA-binding nor transcription activator function.
Beta strand	204 – 212

Literature citations
Mitochondrial transcription factors TFA, TFB1 and TFB2: a search for DNA variants/haplotypes and the risk of cardiac hypertrophy.
Alonso-Montes C.; Castro M.G.; Reguero J.R.; Perrot A.; Ozcelik C.; Geier C.; Posch M.G.; Moris C.; Alvarez V.; Ruiz-Ortega M.; Coto E.;
Dis. Markers 25:131-139(2008)
Cited for: VARIANTS PRO-120; ALA-211 AND GLN-256;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.